NEUROSPECTRUM INSIGHTS (NSIH US): Synthetic Expert Call Transcript (16 Jul 2026)
GyriCalc's regulatory positioning restricts its commercial adoption: The FDA 510(k) clearance (K250686) categorizes it under 21 CFR 892.2050 as a...
104 Views
IPO Databook: NeuroSpectrum Insights (NSIH US) - Jul 2026
NeuroSpectrum Insights is a pre-revenue medical device company commercializing GyriCalc, a patented software for autism diagnosis using MRI...
113 Views
No more insights